Johns Hopkins All Children's Hospital, formerly All Children's Hospital, is a pediatric acute care children's hospital located in St. Petersburg, Florida. The hospital has 259 beds and is affiliated with the USF Morsani College of Medicine and Johns Hopkins University School of Medicine.

During the past decade, Johns Hopkins All Children's Hospital conducted 120 clinical trials. In the 10-year time frame, 120 clinical trials started and 120 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 26 clinical trials started and 43 clinical trials were completed. i.e. 165.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Johns Hopkins All Children's Hospital" #1 sponsor was "Children's Oncology Group" with 154 trials, followed by "National Cancer Institute (NCI)" with 59 trials sponsored, "Johns Hopkins All Children's Hospital" with 18 trials sponsored, "Center for International Blood and Marrow Transplant Research" with 5 trials sponsored and "University of South Florida" with 5 trials sponsored. Other sponsors include 99 different institutions and companies that sponsored additional 82 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Johns Hopkins All Children's Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 164 trials as a collaborator, "Children's Oncology Group" with 12 trials as a collaborator, "Johns Hopkins All Children's Hospital" with 8 trials as a collaborator, "Children's Hospital of Philadelphia" with 6 trials as a collaborator and "National Heart, Lung, and Blood Institute (NHLBI)" with 6 trials as a collaborator. Other collaborators include 173 different institutions and companies that were collaborators in the rest 146 trials.

According to Clinical.Site data, the most researched conditions in "Johns Hopkins All Children's Hospital" are "Recurrent Neuroblastoma" (23 trials), "Leukemia" (22 trials), "Sarcoma" (20 trials), "Recurrent Osteosarcoma" (19 trials) and "Neuroblastoma" (16 trials). Many other conditions were trialed in "Johns Hopkins All Children's Hospital" in a lesser frequency.

Most popular intervention types in "Johns Hopkins All Children's Hospital" are "Drug" (251 trials), "Other" (132 trials), "Biological" (96 trials), "Procedure" (89 trials) and "Radiation" (65 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Cyclophosphamide" (49 trials), "Vincristine Sulfate" (36 trials), "cyclophosphamide" (33 trials) and "etoposide" (32 trials). Other intervention names were less common.

The vast majority of trials in "Johns Hopkins All Children's Hospital" are 340 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Johns Hopkins All Children's Hospital". undefined are not yet recruiting, 63 are recruiting, 70 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 188 completed trials in Johns Hopkins All Children's Hospital, 3 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Johns Hopkins All Children's Hospital, 31 "Phase 1" clinical trials were conducted, 131 "Phase 2" clinical trials and 117 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 27 trials that are defined as “Not Applicable".

Johns Hopkins All Children's Hospital has several departments that took part in Clinical trials: "Johns Hopkins All Children's Hospital Outpatient Care Center" - 7 trials, "All Childrens Hospital Specialty Physicians" - 3 trials, "Johns Hopkins All Children's Heart Institute" - 2 trials, "All Children's Research Institute, Inc." - 2 trials